An experienced structural biologist, Simon Messing, PhD, has served in the position of scientist 3 at the Frederick National Laboratory for Cancer Research in Frederick, Maryland, since 2015. His responsibilities in this role involve the development and optimization of drug screening protocols, with a focus on protein production. In addition to optimizing reagents for drug screening assays, Simon Messing publishes protein production group results with the RAS Initiative and engages with the larger scientific community on relevant topics.
Simon Messing has written or contributed in part to more than 30 publications during his career as a cancer scientist. He is particularly interested in the RAS associated proteins LZTR1 and PIK3. His work in this area resulted in a high-impact publication.
Simon Messing holds a biology degree from Macalester College. He earned his doctor of biophysics from the Johns Hopkins School of Medicine, followed by five years of post-doctoral experience with the National Institutes of Health. Beyond his activities at the Frederick National Laboratory for Cancer Research, his interests include gardening with his neighborhood group and for the Shepherd Elementary School.